Keyphrases
Mouse Model
100%
Tuberculosis
100%
Tofacitinib
100%
Mycobacterium Tuberculosis (M. tb)
50%
Immunocompetent Individual
33%
Sterilization
33%
Janus Kinase
33%
Treatment Efficacy
16%
Macrophages
16%
Inflammatory Cytokines
16%
Host Immune Response
16%
Treatment Protocol
16%
Host Immunity
16%
AIDS/HIV
16%
Multidrug-resistant
16%
Low Adherence
16%
Beta-blockers
16%
Resistant Strains
16%
Treatment Duration
16%
Anti-inflammatory Properties
16%
Mycobacterium Tuberculosis Infection
16%
Granulomatous Lesion
16%
Tuberculosis Treatment
16%
Balb C Mice
16%
Host-directed Therapy
16%
Tuberculosis Outbreak
16%
Rapid Spread
16%
Extensively Drug-resistant
16%
Host-directed
16%
Alternative Host
16%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Tofacitinib
100%
Mycobacterium Tuberculosis
50%
Janus Kinase
33%
HIV
16%
Bagg Albino Mouse
16%
Anti-Inflammatory Drug
16%
C3HeB/Fe Mouse
16%
Cytokine
16%
Infection
16%
Tuberculosis
16%
Granulomatosis
16%
Combination Therapy
16%